Featured Article
Targeting a specific receptor in the eye may benefit patients with age-related macular degeneration, a major cause of blindness worldwide.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
New Vaccine Approach Offers Protection from Coronaviruses That Haven’t Yet Emerged
New research, led by University of Cambridge investigators, shows they have developed a new vaccine technology that provides a broad range of protection against coronaviruses, even those that don’t yet exist.
Colorectal Cancer Screening Interval Could Be Extended
Screening intervals for individuals at average risk of colorectal cancer could be extended in guidelines to avoid unnecessary invasive examinations, Swedish research suggests.
New Treatment Target for Age-Related Macular Degeneration Discovered
Targeting a specific receptor in the eye may benefit patients with age-related macular degeneration, a major cause of blindness worldwide.
